Front page text
ImmunID: Adding Precision to the Immuno-Oncology Revolution by Personalizing Cancer Immunotherapy
ImmunID personalizes immunotherapy for cancer patients. ImmunID’s flagship CE-marked product, ImmunTraCkeR®, evaluates the patient’s immune status from a simple blood sample. The company is establishing ImmunTraCkeR® as the general immune companion diagnostic assay for cancer immunotherapy. ImmunTraCkeR® aims at sparing patients from inadequate treatments & unnecessary side effects, while allowing significant healthcare savings.